CP
TMO icon

Castleview Partners’s Thermo Fisher Scientific TMO Stock Holding History

Castleview Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330K Sell
658
-2
-0.3% -$960 0.15% 155
2026
Q1 		$324K Sell
660
-18
-3% -$9.77K 0.17% 135
2025
Q4 		$393K Sell
678
-4
-0.6% -$2.26K 0.19% 114
2025
Q3 		$331K Sell
682
-798
-54% -$371K 0.18% 121
2025
Q2 		$600K Buy
1,480
+186
+14% +$77.8K 0.39% 60
2025
Q1 		$644K Sell
1,294
-151
-10% -$81.8K 0.44% 58
2024
Q4 		$755K Sell
1,445
-211
-13% -$116K 0.41% 59
2024
Q3 		$1.02M Buy
1,656
+36
+2% +$21.3K 0.59% 33
2024
Q2 		$896K Buy
1,620
+186
+13% +$107K 0.51% 42
2024
Q1 		$833K Buy
1,434
+441
+44% +$247K 0.47% 51
2023
Q4 		$527K Buy
993
+3
+0.3% +$1.45K 0.37% 59
2023
Q3 		$501K Sell
990
-2
-0.2% -$1.07K 0.46% 44
2023
Q2 		$518K Sell
992
-3
-0.3% -$1.62K 0.47% 40
2023
Q1 		$573K Sell
995
-8
-0.8% -$4.51K 0.51% 45
2022
Q4 		$552K Buy
1,003
+570
+132% +$302K 0.54% 44
2022
Q3 		$220K Sell
433
-1,112
-72% -$622K 0.21% 99
2022
Q2 		$200K Buy
1,545
+1,112
+257% +$612K 0.16% 139
2022
Q1 		$255K Sell
433
-288,481
-100% -$166M 0.16% 132
2021
Q4 		$433 Buy
+288,914
New +$180M ﹤0.01% 550
2021
Q2 		$256K Buy
+507
New +$239K 0.11% 192
2018
Q1 		$201K Buy
+972
New +$204K 0.17% 109

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Castleview Partners's TMO Position: Q2 2026 in Review

Castleview Partners reduced its Thermo Fisher Scientific (TMO) stake by 0.3% in Q2 2026, selling an estimated $960 and leaving 658 shares worth $330K. The position accounts for 0.15% of the portfolio, ranked #155.

Castleview Partners first reported a position in TMO in Q1 2018 and has held it in 21 quarters since. The position peaked at $1.02M in Q3 2024. 500 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Castleview Partners held 658 shares of Thermo Fisher Scientific worth $330K as of Q2 2026.
  • Castleview Partners sold 2 Thermo Fisher Scientific shares in Q2 2026, an estimated $960.
  • Thermo Fisher Scientific made up 0.15% of Castleview Partners's portfolio in Q2 2026, its #155 holding.
  • Castleview Partners first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 21 quarters since.
  • Castleview Partners's Thermo Fisher Scientific position peaked at $1.02M in Q3 2024.
  • 500 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.